[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lillian L. Siu<\/i><\/u><\/presenter>. UHN Princess Margaret Cancer Centre, Toronto, ON, Canada","CSlideId":"","ControlKey":"6189b9aa-71c7-4648-bbac-d659ccf40524","ControlNumber":"12192","DisclosureBlock":"","End":"4\/8\/2024 5:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"11892","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lillian Siu, MD","PresenterKey":"7501fbfb-af2e-4490-8f84-1f5ea25999e8","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Circulating tumor DNA to enable interception of molecular residual disease in solid tumors","SearchResultFooter":"","SearchResultHeader":"Apr  8 2024  5:00PM","SessionId":"675","SessionOnDemand":"False","SessionTitle":"Circulating Tumor DNA to Enable Interception of Molecular Residual Disease in Solid Tumors","ShowChatLink":"false","Start":"4\/8\/2024 5:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Circulating tumor DNA to enable interception of molecular residual disease in solid tumors","Topics":null,"cSlideId":""}]